“The lab has already been set up and the first set of results will come in the next 4-5 days. Yesterday, we launched a similar laboratory at Lok Nayak Hospital, but this is going to be an even more advanced one. I really feel that the people of Delhi will highly benefit from this lab and the facility that it will cater to,” Kejriwal said.
“Until now, we were dependent on National Cooperative Development Corporation and other centres of the Central government for this sequencing. But now, we are independent and will be able to identify the variants on time and take the right actions so as to strategise our plans for any next wave, if at all it comes,” he said.
Kejriwal said the facility will help in generating state-of-the-art whole genome sequence data of the SARS CoV-2 virus for identification and screening of new strains and variants with clinical significance, circulating in and around the Delhi-NCR region.
The facility can sequence nearly all 30,000 molecules of the COVID-19, in fact, the whole length of the virus, he said. By doing this, any mutations in any part of the virus can be identified and not merely the spike protein area.
The facility at ILBS, he said, is equipped with the latest machines called the NextSeq and MiSeq which can sequence the whole virus to the tune of 400 sequences per week.